Vertanical Denmark ApS
Private limited companyCVR 40227792MarslevActive
Vertanical Denmark ApS is a private limited company, based in Marslev, active in manufacture of other organic basic chemicals, founded in 2019. Net profit rose 28% from 2024 to 2025, ending at DKK 1.2m. Profit has grown three years in a row. Equity grew to DKK 5.2m in 2025.
Key figures · financial year 2025
What has changed
calculated from recorded figures and datesFinancials: 2025 against 2024
- Gross profit rose 5% (2024 → 2025), to DKK 33.7m.
- Net profit rose 28% (2024 → 2025), to DKK 1.2m.
- Equity rose 29% (2024 → 2025), to DKK 5.2m.
Employees
- 3 fewer employees than a year earlier: 23 (07/2026) against 26 (07/2025).
Registrations, last 24 months
- 01/01/2025: Industry changed to Manufacture of other organic basic chemicals (201400)
Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.
Financial statements
Financial years 2020–2025 · amounts in DKK thousandEquity and net profit
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change | |
|---|---|---|---|---|---|---|---|
| Revenue | not stated | not stated | not stated | not stated | not stated | not stated | – |
| Gross profit | 17,914 | 22,885 | 32,424 | 34,916 | 32,110 | 33,712 | +5% |
| Operating profit (EBIT) | 1,970 | 2,146 | 2,523 | 2,403 | 2,185 | 2,451 | +12.2% |
| Profit before tax | 1,180 | 977 | 1,400 | 976 | 1,200 | 1,513 | +26.1% |
| Net profit | 749 | 528 | 1,077 | 720 | 910 | 1,167 | +28.3% |
| Total assets | 186,872 | 183,102 | 216,628 | 191,380 | 173,757 | 169,356 | −2.5% |
| Equity | 821 | 1,349 | 2,426 | 3,146 | 4,056 | 5,222 | +28.8% |
| Liabilities | 185,620 | 180,899 | 212,999 | 186,783 | 167,953 | 162,039 | −3.5% |
| Cash and cash equivalents | 590 | 10,324 | 1,908 | 791 | 805 | 1,248 | +55.1% |
| Average number of employees | 12 | 30 | 31 | 22 | 22 | 25 | +13.6% |
Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2020, 2021, 2022, 2023, 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.
Download the figures as CSV · free with an account, amounts in whole DKK
Signals from the financial statements
calculated from the 2025 figuresLow equity ratio
Equity makes up 3% of total assets in 2025.
How is this calculated?
Equity ÷ total assets is below 10% in the latest annual report. Banks, insurers and some industries naturally have a low ratio.
Profit for five years in a row
Net result has been positive in 2021–2025.
How is this calculated?
Net result is positive in the five latest annual reports in a row.
The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.
Annual reports
6 financial years| Financial year | Period | Published | Figures for | Documents |
|---|---|---|---|---|
| 2025 | 01/01/2025 – 31/12/2025 | 04/08/2026 | The company | PDF not statedXBRL |
| 2024 | 01/01/2024 – 31/12/2024 | 08/07/2025 | The company | PDF not statedXBRL |
| 2023 | 01/01/2023 – 31/12/2023 | 05/08/2024 | The company | PDFXBRL |
| 2022 | 01/01/2022 – 31/12/2022 | 02/07/2023 | The company | PDFXBRL |
| 2021 | 01/01/2021 – 31/12/2021 | 06/07/2022 | The company | PDFXBRL |
| 2020 | 01/01/2020 – 31/12/2020 | 23/07/2021 | The company | PDFXBRL |
The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.
Employees
monthly figures from CVRPosition in the industry
9 companies in the databaseComparison with the other companies in manufacture of other organic basic chemicals based on the latest financial year.
Industry median: gross profit DKK 7.9m, net profit DKK 1.2m, equity DKK 7.3m, 12 employees.
Compared with similar companies
size, age and company form| Group | Gross profit | Equity |
|---|---|---|
| Companies with 20–49 employees9,922 companies in the comparison | No. 1,066of 9,892 Better than 89% | No. 4,626of 9,922 Better than 53% |
| Companies that are between 5 and 14 years old33,688 companies in the comparison | No. 1,116of 33,588 Better than 97% | No. 5,908of 33,687 Better than 82% |
| All companies of type ApS66,508 companies in the comparison | No. 1,230of 66,379 Better than 98% | No. 10,922of 66,505 Better than 84% |
The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.
Compare with the industry
Manufacture of other organic basic chemicals- Vertanical Denmark ApSDKK 33.7m
- Novozymes A/SDKK 2.2bn
- Syntese A/SDKK 159m
- Vertanical Denmark ApSDKK 1.2m
- Novozymes A/SDKK 583.6m
- Syntese A/SDKK 8.7m
- Vertanical Denmark ApSDKK 5.2m
- Novozymes A/SDKK 10.9bn
- Syntese A/SDKK 84.6m
- Vertanical Denmark ApS23
- Novozymes A/S3,508
- Syntese A/S156
Latest financial year per company. Choose up to three companies from the largest in the industry.
Owners and group
from the Public Ownership Register- Futrue Gmbh66.67%
- MVH Beteiligungs- und Beratungs-GmbH15%
Management
1 active registrationsExecutive management
| Name | Role | Appointed |
|---|---|---|
| Bastian Baasch | Director | 12/10/2021 |
- Founders
- Futrue Gmbh
Former management (6)
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| Clemens Fischer | CEO | 01/02/2019 | 05/02/2020 |
| Bastian Baasch | Director | 01/02/2019 | 04/06/2020 |
| Andreas Raabe | CEO | 05/02/2020 | 05/06/2020 |
| Christian Westebbe | Director | 05/02/2020 | 30/10/2020 |
| Bastian Baasch | CEO | 05/06/2020 | 11/10/2021 |
| Thomas Clement Guldager | CEO | 12/10/2021 | 08/12/2022 |
Signing rule: Selskabet tegnes af en direktør alene.
Address and production units
1 active production unitsBirketvedvejen 31
5290 Marslev
| Production unit | Address | Employees | P number |
|---|---|---|---|
| Vertanical Denmark ApS | Birketvedvejen 31, 5290 Marslev | 23 | 1024369796 |
Purpose
Selskabets formål er at drive virksomhed i ind- og udland inden for produktion, distribution og markedsføring af helse- og sundhedsprodukter, i særdeleshed i hensyn til lægemidler, medicinsk udstyr, kosttilskud og kosmetik, samt enhver anden i forbindelse hermed tilknyttet virksomhed.
The purpose is quoted from the register in Danish.
Changes year by year
25 registered events20261 changeaccounts 1
- AccountsAnnual report for 2025 published
20252 changesaccounts 1 · industry 1
- AccountsAnnual report for 2024 published
- IndustryIndustry changed to Manufacture of other organic basic chemicals (201400)
20241 changeaccounts 1
- AccountsAnnual report for 2023 published
20231 changeaccounts 1
- AccountsAnnual report for 2022 published
20222 changesmanagement 1 · accounts 1
- ManagementThomas Clement Guldager stepped down as ceo
- AccountsAnnual report for 2021 published
20214 changesmanagement 3 · accounts 1
- ManagementThomas Clement Guldager appointed ceo
- ManagementBastian Baasch appointed director
- ManagementBastian Baasch stepped down as ceo
- AccountsAnnual report for 2020 published
20207 changesmanagement 7
- ManagementChristian Westebbe stepped down as director
- ManagementBastian Baasch appointed ceo
- ManagementAndreas Raabe stepped down as ceo
- ManagementBastian Baasch stepped down as director
- ManagementChristian Westebbe appointed director
- ManagementAndreas Raabe appointed ceo
- ManagementClemens Fischer stepped down as ceo
20197 changesaddress 1 · name 1 · founded 1 · management 2 · ownership 2
- AddressMoved to Birketvedvejen 31, 5290 Marslev
- NameName changed from LHL Pharma Denmark ApS to Vertanical Denmark ApS
- FoundedRegistered as LHL Pharma Denmark ApS
- ManagementClemens Fischer appointed ceo
- ManagementBastian Baasch appointed director
- OwnershipFUTRUE GmbH registered as owner (66.67%)
- OwnershipMVH Beteiligungs- und Beratungs-GmbH registered as owner (15%)
Related companies
Same people in management
- Xellia Pharmaceuticals ApSvia Thomas Clement Guldager
Largest in the industry
- Novozymes A/SDKK 2.2bn
- Syntese A/SDKK 159m
- Kemi-Tech ApSDKK 26.6m
- Burnblock ApSDKK 7.9m
- Grolman Nordic Specialty Chemicals ApSDKK 5.8m
- Valcon Medical A/SDKK 2.1m
Source and updates
The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.